Bionano Genomics (BNGO) Long-Term Debt Issuances (2018 - 2023)

Bionano Genomics' Long-Term Debt Issuances history runs 4 years deep, the most recent figure standing at $80.0 million for Q4 2023.

• In Q4 2023, Long-Term Debt Issuances changed N/A year-over-year to $80.0 million; the TTM figure through Sep 2025 stood at $80.0 million (down 0.94% YoY), while the FY2024 annual figure was $18.0 million, down 77.5% from the prior year.
• Long-Term Debt Issuances came in at $80.0 million for Q4 2023 at Bionano Genomics, up from $761000.0 in the prior quarter.
• In the past five years, Long-Term Debt Issuances ranged from a high of $80.0 million in Q4 2023 to a low of -$14.1 million in Q4 2019.
• A 3-year average of $17.2 million and a median of $761000.0 in 2020 frame the typical range for Long-Term Debt Issuances.
• Across the five-year window, Long-Term Debt Issuances slumped 247.95% in 2019 and jumped 105.41% in 2020, its largest moves.
• Bionano Genomics' Long-Term Debt Issuances stood at -$14.1 million in 2019, then surged by 105.41% to $761000.0 in 2020, then surged by 10412.48% to $80.0 million in 2023.
• According to Business Quant data, Long-Term Debt Issuances over the past three periods registered $80.0 million, $761000.0, and -$14.1 million for Q4 2023, Q4 2020, and Q4 2019 respectively.

Peer Comparison